Please provide your email address to receive an email when new articles are posted on . A universal model predicted CV events for people with and without baseline atherosclerotic CVD. Some patients ...

A risk calculator that incorporates established cardiovascular risk factors and additional cardiac biomarkers, such as high-sensitivity C-reactive protein (hs-CRP) and N-terminal pro-B-type ...

The problem with daily aspirin use is the risk of bleeding, as seen time and time again in major randomized trials. In the ...

Please provide your email address to receive an email when new articles are posted on . PCSK9 inhibition demonstrated benefit in the broader primary prevention population for LDL lowering and plaque ...

Both women and men with atherosclerotic cardiovascular disease (ASCVD) who take aspirin as secondary prevention fare just as well, for the most part, whether they’re on 81 mg or 325 mg daily, ...

NEW ORLEANS -- People with diabetes may be among those who still benefit from primary prevention aspirin, a large observational study suggested. In contrast with the unimpressive track record of ...

Hypertension control is critical to prevent stroke. With several clinical trials conducted over the last decade, it seems that the use of an angiotensin-modulating antihypertensive agent conveys ...